NCT00270946已完成不适用
A Pivotal Study to Evaluate the Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (OrCel) for the Treatment of Venous Ulcers
Ortec International2 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2002年4月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 130
- 试验地点
- 2
- 主要终点
- Investigator assessment of wound healing
研究概览
简要总结
This study was designed to evaluate the clinical benefits and safety of OrCel in the treatment of venous ulcers. OrCel and standard care were compared to standard care alone. Standard care consisted of currently accepted compression therapy.
Patients were treated for 12 weeks. Patients with healed ulcers were followed for an additional 12 weeks to assess durability of the healed wound.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Any race, between 18 and 85 years of age
- •Male or female
- •Chronic venous insufficiency
- •Ulcer size between 2 and 20 sq cm, inclusive
- •Ulcer present for at least one month
- •ABI >0.7
排除标准
- •Decrease in wound size >35% during Screening Phase
- •Infection at the ulcer site
- •Uncontrolled diabetes mellitus
- •Previous treatment with excluded medications
结局指标
主要结局
Investigator assessment of wound healing
次要结局
- Planimetric assessment of wound healing
- Photographic assessment of wound healing
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
The Evaluation of OrCel for the Treatment of Venous UlcersVenous InsufficiencyLeg UlcerNCT00270972Ortec International60
Unknown
4 期
A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser in Asian Eyes Using LASIKMyopiaHyperopiaPresbyopiaNCT01977807Technolas Perfect Vision GmbH100
Unknown
4 期
A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIKMyopiaHyperopiaNCT02071576Technolas Perfect Vision GmbH42
Unknown
4 期
A Prospective Safety and Effectiveness Study of a New High Repetition Rate Excimer Laser Using LASIK for the Correction of Ammetropia and PresbyopiaHyperopiaPresbyopiaMyopiaNCT02112968Technolas Perfect Vision GmbH97
招募中
1 期
Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALLLymphoblastic Leukemia, Acute, ChildhoodLeukemia, Lymphoblastic, Acute, Philadelphia-PositiveRelapsed LeukemiaRefractory LeukemiaNCT05495035Institute of Hematology & Blood Diseases Hospital, China19